A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2026-01-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113
compared with placebo in participants with moderately to severely active ulcerative colitis.